Catalent (Germany) Top Insiders

0C8 Stock  EUR 59.93  0.29  0.48%   
Catalent employs about 19 K people. The company is managed by 10 executives with a total tenure of roughly 21 years, averaging almost 2.0 years of service per executive, having 1900.0 employees per reported executive. Examination of Catalent's management performance can provide insight into the company performance.
John Chiminski  Chairman
Chairman of the Board and Presidentident, CEO
Aristippos Gennadios  President
President - Softgel Technologies
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Catalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Catalent Stock please use our How to Invest in Catalent guide.

Catalent Management Team Effectiveness

The company has return on total asset (ROA) of 0.041 % which means that it generated a profit of $0.041 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0873 %, meaning that it generated $0.0873 on every $100 dollars invested by stockholders. Catalent's management efficiency ratios could be used to measure how well Catalent manages its routine affairs as well as how well it operates its assets and liabilities.

Catalent Workforce Comparison

Catalent is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is presently estimated at about 233,020. Catalent holds roughly 19,000 in number of employees claiming about 8% of equities under Drug Manufacturers - Specialty & Generic industry.
The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.

Catalent Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Catalent Price Series Summation is a cross summation of Catalent price series and its benchmark/peer.

Catalent Notable Stakeholders

A Catalent stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Catalent often face trade-offs trying to please all of them. Catalent's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Catalent's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John ChiminskiChairman of the Board and Presidentident, CEOProfile
Aristippos GennadiosPresident - Softgel TechnologiesProfile
Alessandro MaselliSenior Vice President - Global OperationsProfile
Thomas CastellanoVP CFOProfile
Paul SurdezVP RelationsProfile
Steven EsqCorp VPProfile
Julien MeissonnierVP OfficerProfile
Karen SantiagoVP OfficeProfile
Ricky HopsonPres SupplyProfile
Charles LickfoldVP OfficerProfile

About Catalent Management Performance

The success or failure of an entity such as Catalent often depends on how effective the management is. Catalent management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Catalent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Catalent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey. Catalent operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11000 people.

Catalent Workforce Analysis

Traditionally, organizations such as Catalent use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Catalent within its industry.

Catalent Manpower Efficiency

Return on Catalent Manpower

Revenue Per Employee254.1K
Revenue Per Executive482.8M
Net Income Per Employee27.3K
Net Income Per Executive51.9M

Complementary Tools for Catalent Stock analysis

When running Catalent's price analysis, check to measure Catalent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalent is operating at the current time. Most of Catalent's value examination focuses on studying past and present price action to predict the probability of Catalent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalent's price. Additionally, you may evaluate how the addition of Catalent to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Share Portfolio
Track or share privately all of your investments from the convenience of any device